Edwards Lifesciences (EW) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $86.35 +0.55%
Revenue Growth %: +11.1%
Financial Fact:
Basic (in dollars per share): 0.66
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +11.1%
Financial Fact:
Basic (in dollars per share): 0.66
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.66, $0.01 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.5 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Creatd files Form S-1 and reports Q1 2026 financial results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
